Dr. Loehrer, who was one of the original four medical oncologists at the Indiana University School of Medicine, will continue in his role as medical director of the IU Simon Cancer Center. He is an internationally recognized researcher and specialist in testicular cancer, gastrointestinal cancer and thymoma.
Dr. Loehrer is the Kenneth Wiseman Professor of Medicine and director of the Division of Hematology-Oncology for the IU School of Medicine. For the past four years, he has served as deputy director at the IU Simon Cancer Center. For two decades, he served as the founding chair of the Hoosier Oncology Group, a statewide collaboration of academic and community oncologists that united for the purpose of conducting clinical trials in the community setting.
He is principal investigator at Indiana University for the Eastern Cooperative Oncology Group, one of the first and largest cooperative groups of researchers and health professionals focused on conducting multi-center cancer clinical trials. Dr. Loehrer has served on the board of directors of the American Board of Internal Medicine and was chair of the Medical Oncology Subcommittee. He was recently appointed to the Oncology Drug Advisory Committee of the Food and Drug Administration (FDA).
Dr. Loehrer earned his medical degree from Rush Medical College in Chicago in 1978. He completed an internship and residency in internal medicine at Rush-Presbyterian St. Luke’s Medical Center prior to completing his medical oncology fellowship at Indiana University.
Dr. Loehrer succeeds the late Stephen Williams, M.D., the founding director of the IU Simon Cancer Center, who died Feb. 15.
A national search is underway for a director of the IU Simon Cancer Center.